Recombinant human CD30/TNFRSF8 protein

Cat No.
ATGP3389

Size

QTY

List Price

10ug

USD 83


20ug

USD 143

50ug

USD 195

100ug

USD 323

250ug

USD 563

500ug

USD 968

1mg

USD 1,613

USD 0



Product Information

Product Type
Recombinant Protein
Expression System
Baculovirus
Domain
19-379aa
UniProt No.
P28908
NCBI Accession No.
NP_001234
Alternative names
Tumor necrosis factor receptor superfamily member 8, TNFRSF8, CD30, D1S166E, Ki-1, CD 30, CD30 antigen, CD30L receptor, Cytokine receptor CD30, D1S166E, KI 1, KI 1 antigen, Ki-1 antigen, KI1, Lymphocyte activation antigen CD30, TNFRSF 8, Tnfrsf8, TNR8_HUMAN, Tumor necrosis factor receptor superfamily member 8

Product Specification

Molecular Weight
66.7 kDa (613aa)
Concentration
0.5mg/ml (determined by absorbance at 280nm)
Formulation
Liquid in. Phosphate-Buffered Saline (pH 7.4) containing 10% glycerol
Purity
> 85% by SDS-PAGE
Bioactivity
Measured by its binding ability in a functional ELISA with Human CD30 Ligand/TNFSF8 (CAT# ATGP3343). The ED50 range ≤ 100 ng/ml.
Endotoxin
< 1 EU per 1ug of protein (determined by LAL method)
Tag
hIgG-His-Tag
Applications
SDS-PAGE, Bioactivity
Storage
Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Data

SDS-PAGE

3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain

Biological Activity

Human CD30 Ligand/TNFSF8 (CAT# ATGP3343) is coated at 2 ug/ml (100 ul/well) can bind Human CD30/TNFRSF8. The ED50 range ≤ 100 ng/ml.

Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.